Skip to content
10-Q

Quarterly Report

SIGNPATH PHARMA, INC.

0001493152-16-009856

← back to feed
Filed
May 16, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 15, 2016 14.2M sh
Operating Cash Flow Q1 2016 · Mar 31, 2016 −$231.41K
Operating Cash Flow Q1 2016 · Mar 31, 2015 −$473.83K
Stockholders Equity Q1 2016 · Mar 31, 2016 $560.09K
Stockholders Equity Q1 2016 · Dec 31, 2015 $388.14K
Current Liabilities Q1 2016 · Mar 31, 2016 $235.91K
Current Liabilities Q1 2016 · Dec 31, 2015 $309.8K
Current Assets Q1 2016 · Mar 31, 2016 $796K
Current Assets Q1 2016 · Dec 31, 2015 $697.93K
Total Assets Q1 2016 · Mar 31, 2016 $796K
Total Assets Q1 2016 · Dec 31, 2015 $697.93K
Sga Expense Q1 2016 · Mar 31, 2016 $36.39K
Sga Expense Q1 2016 · Mar 31, 2015 $50.54K
Rd Expense Q1 2016 · Mar 31, 2016 $70.94K
Rd Expense Q1 2016 · Mar 31, 2015 $216.5K
Net Income Q1 2016 · Mar 31, 2016 −$394.08K
Net Income Q1 2016 · Mar 31, 2015 −$445.46K
Operating Income Q1 2016 · Mar 31, 2016 −$396.25K
Operating Income Q1 2016 · Mar 31, 2015 −$452.1K